Ocean Biomedical Inc OCEA
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.01 / $0.01
- Shares Outstanding
- 232.37M
- Market Cap
- $139,419.09
- Volume/Avg
- 312 / 79,494
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 7
- Website
- https://www.oceanbiomedical.com
Valuation
|
Metric
|
OCEA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
OCEA
Financial Strength
|
Metric
|
OCEA
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.06 |
Interest Coverage | −16.53 |
Quick Ratio
OCEA
Profitability
|
Metric
|
OCEA
|
|---|---|
Return on Assets (Normalized) | −552.42% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
OCEA
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|&&>F@# | LOCK|dgpJ | $127B | |||
| Moderna Inc
MRNA
| LOCK|Nm?gF%W | LOCK|F#n | $87B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|RZ<?!!y | LOCK|bF>D# | $81B | |||
| argenx SE ADR
ARGX
| LOCK|nZ>??Q | LOCK|x<W | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|Sd>^&# | LOCK|%k | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|y!vBJ# | LOCK|q>TV | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|mZ^X&jcq | LOCK|z@Nj | $27B | |||
| Incyte Corp
INCY
| LOCK|^V!Fqz | LOCK|w% | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|ms<%?n | LOCK|^<D | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|tGhqP#< | LOCK|#Q | $14B |
United States